Clinical Trial Update: Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating Zuberitamab in combination with bendamustine, followed by maintenance, for treatment-naïve follicular lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Treanda (Bendamustine)
• Zuberitamab (Zuberitamab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Follicular Lymphoma (FL) | Phase 2 | Status: NOT_YET_RECRUITING